Skip to main content

Boston Partners

SEC CIK
0001386060
Latest filing
Aug 4, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Boston Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
4,784,316
Value
$1.20B
% of portfolio
1.1%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Boston Partners, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,784,316$1.20B1.1%+1,350,106+39.3%AddedHolders
Q1 20263,434,210$746.1M0.8%+33,989+1.0%AddedHolders
Q4 20253,400,221$775.9M0.8%−413,867−10.9%ReducedHolders
Q3 20253,814,088$883.0M0.9%−1,138,710−23.0%ReducedHolders
Q2 20254,952,798$921.9M1.0%−1,392,498−21.9%ReducedHolders
Q1 20256,345,296$1.32B1.6%+657,824+11.6%AddedHolders
Q4 20245,687,472$1.01B1.2%+1,503,875+35.9%AddedHolders
Q3 20244,183,597$824.8M1.0%−2,680−0.1%ReducedHolders
Q2 20244,186,277$717.9M0.9%+3,012,735+256.7%AddedHolders
Q1 20241,173,542$213.5M0.3%−29,272−2.4%ReducedHolders
Q4 20231,202,814$186.5M0.2%−93,821−7.2%ReducedHolders
Q3 20231,296,635$193.2M0.3%−48,271−3.6%ReducedHolders
Q2 20231,344,906$181.3M0.2%−1,607,247−54.4%ReducedHolders
Q1 20232,952,153$470.0M0.6%−2,116,654−41.8%ReducedHolders
Q4 20225,068,807$816.9M1.1%−1,081,267−17.6%ReducedHolders
Q3 20226,150,074$827.3M1.2%+174,102+2.9%AddedHolders
Q2 20225,975,972$913.3M1.3%+549,279+10.1%AddedHolders
Q1 20225,426,693$880.8M1.1%−12,866−0.2%ReducedHolders
Q4 20215,439,559$736.5M0.9%+379,250+7.5%AddedHolders
Q3 20215,060,309$546.0M0.7%+589,506+13.2%AddedHolders
Q2 20214,470,803$503.8M0.6%+1,168,684+35.4%AddedHolders
Q1 20213,302,119$357.5M0.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.